Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 6 | 2024 | 129 | 3.340 |
Why?
|
| Glioma | 6 | 2023 | 92 | 2.890 |
Why?
|
| Glioblastoma | 4 | 2024 | 69 | 2.890 |
Why?
|
| Blood Platelets | 4 | 2020 | 80 | 2.230 |
Why?
|
| Focal Adhesion Kinase 2 | 4 | 2023 | 13 | 1.090 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 972 | 1.060 |
Why?
|
| Thrombosis | 2 | 2018 | 81 | 1.030 |
Why?
|
| Ploidies | 1 | 2025 | 7 | 0.930 |
Why?
|
| Neuroblastoma | 1 | 2025 | 134 | 0.850 |
Why?
|
| Mice, Inbred C57BL | 9 | 2023 | 1804 | 0.790 |
Why?
|
| Cytochromes c | 2 | 2019 | 48 | 0.740 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2019 | 95 | 0.720 |
Why?
|
| Astrocytes | 7 | 2019 | 244 | 0.680 |
Why?
|
| Amyloidosis | 1 | 2020 | 38 | 0.660 |
Why?
|
| Signal Transduction | 3 | 2024 | 2111 | 0.610 |
Why?
|
| Animals | 19 | 2023 | 16695 | 0.600 |
Why?
|
| Parkinson Disease | 1 | 2020 | 207 | 0.570 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 933 | 0.570 |
Why?
|
| Glaucoma | 1 | 2019 | 98 | 0.550 |
Why?
|
| Connexin 43 | 2 | 2017 | 41 | 0.540 |
Why?
|
| Gap Junctions | 2 | 2017 | 49 | 0.540 |
Why?
|
| Mice | 9 | 2023 | 6490 | 0.530 |
Why?
|
| Peptide Fragments | 1 | 2019 | 301 | 0.530 |
Why?
|
| Skin | 1 | 2018 | 185 | 0.520 |
Why?
|
| Entorhinal Cortex | 1 | 2016 | 12 | 0.520 |
Why?
|
| Polyamines | 1 | 2017 | 32 | 0.520 |
Why?
|
| Brain | 3 | 2020 | 1452 | 0.510 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 43 | 0.500 |
Why?
|
| Visual Cortex | 1 | 2016 | 65 | 0.500 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 2598 | 0.450 |
Why?
|
| Microglia | 1 | 2015 | 204 | 0.400 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 27 | 0.390 |
Why?
|
| Staining and Labeling | 1 | 2012 | 106 | 0.380 |
Why?
|
| Humans | 15 | 2025 | 42163 | 0.350 |
Why?
|
| Neurons | 1 | 2017 | 1246 | 0.310 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 2015 | 63 | 0.280 |
Why?
|
| Spermine | 2 | 2017 | 65 | 0.220 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2024 | 21 | 0.220 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 223 | 0.220 |
Why?
|
| Survival Rate | 1 | 2025 | 353 | 0.210 |
Why?
|
| Male | 5 | 2025 | 22779 | 0.210 |
Why?
|
| Embryo Implantation | 1 | 2023 | 32 | 0.200 |
Why?
|
| Rats | 6 | 2017 | 3701 | 0.200 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 1554 | 0.200 |
Why?
|
| Glutamic Acid | 2 | 2015 | 131 | 0.190 |
Why?
|
| Flow Cytometry | 1 | 2023 | 411 | 0.180 |
Why?
|
| Female | 5 | 2025 | 24018 | 0.180 |
Why?
|
| Infant | 1 | 2025 | 1143 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2019 | 1617 | 0.170 |
Why?
|
| Membrane Potentials | 5 | 2015 | 221 | 0.170 |
Why?
|
| Child, Preschool | 1 | 2025 | 1516 | 0.170 |
Why?
|
| Cell Survival | 1 | 2023 | 934 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2017 | 385 | 0.160 |
Why?
|
| Puerto Rico | 1 | 2024 | 1376 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2020 | 112 | 0.150 |
Why?
|
| Folic Acid | 1 | 2019 | 49 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2018 | 400 | 0.150 |
Why?
|
| Dermis | 1 | 2018 | 9 | 0.140 |
Why?
|
| Hypercalcemia | 1 | 2017 | 13 | 0.130 |
Why?
|
| Platelet Count | 1 | 2016 | 12 | 0.130 |
Why?
|
| Potassium | 3 | 2015 | 109 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 199 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 21 | 0.130 |
Why?
|
| Child | 1 | 2025 | 3381 | 0.130 |
Why?
|
| Acidosis | 1 | 2017 | 51 | 0.130 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 209 | 0.130 |
Why?
|
| Photic Stimulation | 1 | 2016 | 123 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2015 | 534 | 0.120 |
Why?
|
| Sweetening Agents | 1 | 2015 | 12 | 0.120 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2015 | 14 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 22 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 188 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 136 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 928 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 284 | 0.110 |
Why?
|
| Calcium | 1 | 2017 | 487 | 0.110 |
Why?
|
| Glucose | 1 | 2015 | 242 | 0.110 |
Why?
|
| Adolescent | 1 | 2025 | 5950 | 0.100 |
Why?
|
| Seizures | 2 | 2010 | 79 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 658 | 0.100 |
Why?
|
| Spermidine | 1 | 2012 | 34 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 34 | 0.100 |
Why?
|
| Cell Communication | 1 | 2012 | 110 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 254 | 0.090 |
Why?
|
| Aged | 1 | 2024 | 7982 | 0.090 |
Why?
|
| Cell Movement | 1 | 2015 | 640 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2016 | 449 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 38 | 0.080 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2010 | 13 | 0.080 |
Why?
|
| Ion Channel Gating | 1 | 2010 | 81 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1066 | 0.080 |
Why?
|
| Potassium Channels | 1 | 2010 | 81 | 0.080 |
Why?
|
| Quinolines | 1 | 2010 | 76 | 0.080 |
Why?
|
| Middle Aged | 1 | 2024 | 11819 | 0.070 |
Why?
|
| Adult | 1 | 2024 | 13458 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 3 | 2015 | 228 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 1169 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 1737 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 64 | 0.030 |
Why?
|
| Micelles | 1 | 2016 | 36 | 0.030 |
Why?
|
| Neocortex | 1 | 2015 | 27 | 0.030 |
Why?
|
| Colorimetry | 1 | 2015 | 52 | 0.030 |
Why?
|
| Hela Cells | 1 | 2016 | 370 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 74 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 151 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2016 | 169 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 79 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 350 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 574 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 273 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 2012 | 27 | 0.020 |
Why?
|
| Carbenoxolone | 1 | 2012 | 10 | 0.020 |
Why?
|
| Giant Cells | 1 | 2012 | 15 | 0.020 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2012 | 35 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2012 | 50 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1112 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 182 | 0.020 |
Why?
|
| Channelopathies | 1 | 2010 | 5 | 0.020 |
Why?
|
| Ataxia | 1 | 2010 | 8 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Barium | 1 | 2010 | 16 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1848 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 10 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 73 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 72 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 135 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 271 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 113 | 0.020 |
Why?
|
| Neuroglia | 1 | 2010 | 131 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 114 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 427 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 526 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1541 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 1188 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1559 | 0.020 |
Why?
|
| Hippocampus | 1 | 2010 | 591 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 875 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 727 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1416 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 860 | 0.020 |
Why?
|